| Constance Dyas Callen, CRNP | |
|
1965 1st Ave, Opelika, AL 36801-5403 | |
| (334) 705-0012 | |
| Not Available |
| Full Name | Constance Dyas Callen |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 1965 1st Ave, Opelika, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073172805 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 1-137962 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| East Alabama Ear, Nose, And Throat, Pc | 0749217776 | 8 |
| Village Urgent Care | 5890140974 | 3 |
News Archive
"The incidence of dengue has grown dramatically around the world in recent decades," the WHO writes in an updated fact sheet about dengue and severe dengue published on the organization's website. According to the fact sheet, "Over 2.5 billion people - over 40 percent of the world's population - are now at risk from dengue," and "WHO currently estimates there may be 50-100 million dengue infections worldwide every year."
An experimental drug can improve sociability in patients with fragile X syndrome and may be helpful as a treatment for autism, according to the authors of a new study.
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR TherapeuticsTM, today announced that it has initiated a Phase 2 clinical proof of concept trial of TC-5619 in cognitive dysfunction in schizophrenia.
A patient with recurrent metastatic colorectal cancer has been successfully treated with the angiotensin receptor blocker irbesartan, researchers report.
Intravenous, low-dose ketamine is as effective as intravenous morphine in the control of acute pain in adults in the emergency department.
› Verified 8 days ago
| Entity Name | East Alabama Ear, Nose, & Throat, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942228655 PECOS PAC ID: 0749217776 Enrollment ID: O20050721000531 |
News Archive
"The incidence of dengue has grown dramatically around the world in recent decades," the WHO writes in an updated fact sheet about dengue and severe dengue published on the organization's website. According to the fact sheet, "Over 2.5 billion people - over 40 percent of the world's population - are now at risk from dengue," and "WHO currently estimates there may be 50-100 million dengue infections worldwide every year."
An experimental drug can improve sociability in patients with fragile X syndrome and may be helpful as a treatment for autism, according to the authors of a new study.
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR TherapeuticsTM, today announced that it has initiated a Phase 2 clinical proof of concept trial of TC-5619 in cognitive dysfunction in schizophrenia.
A patient with recurrent metastatic colorectal cancer has been successfully treated with the angiotensin receptor blocker irbesartan, researchers report.
Intravenous, low-dose ketamine is as effective as intravenous morphine in the control of acute pain in adults in the emergency department.
› Verified 8 days ago
| Entity Name | Village Urgent Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053093682 PECOS PAC ID: 5890140974 Enrollment ID: O20231010000694 |
News Archive
"The incidence of dengue has grown dramatically around the world in recent decades," the WHO writes in an updated fact sheet about dengue and severe dengue published on the organization's website. According to the fact sheet, "Over 2.5 billion people - over 40 percent of the world's population - are now at risk from dengue," and "WHO currently estimates there may be 50-100 million dengue infections worldwide every year."
An experimental drug can improve sociability in patients with fragile X syndrome and may be helpful as a treatment for autism, according to the authors of a new study.
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR TherapeuticsTM, today announced that it has initiated a Phase 2 clinical proof of concept trial of TC-5619 in cognitive dysfunction in schizophrenia.
A patient with recurrent metastatic colorectal cancer has been successfully treated with the angiotensin receptor blocker irbesartan, researchers report.
Intravenous, low-dose ketamine is as effective as intravenous morphine in the control of acute pain in adults in the emergency department.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Constance Dyas Callen, CRNP 844 Annabrook Dr, Auburn, AL 36830-7530 Ph: () - | Constance Dyas Callen, CRNP 1965 1st Ave, Opelika, AL 36801-5403 Ph: (334) 705-0012 |
News Archive
"The incidence of dengue has grown dramatically around the world in recent decades," the WHO writes in an updated fact sheet about dengue and severe dengue published on the organization's website. According to the fact sheet, "Over 2.5 billion people - over 40 percent of the world's population - are now at risk from dengue," and "WHO currently estimates there may be 50-100 million dengue infections worldwide every year."
An experimental drug can improve sociability in patients with fragile X syndrome and may be helpful as a treatment for autism, according to the authors of a new study.
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR TherapeuticsTM, today announced that it has initiated a Phase 2 clinical proof of concept trial of TC-5619 in cognitive dysfunction in schizophrenia.
A patient with recurrent metastatic colorectal cancer has been successfully treated with the angiotensin receptor blocker irbesartan, researchers report.
Intravenous, low-dose ketamine is as effective as intravenous morphine in the control of acute pain in adults in the emergency department.
› Verified 8 days ago
Warren A Stiles, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1965 1st Ave, Opelika, AL 36801 Phone: 334-705-0012 Fax: 334-705-0378 | |
Mr. Wesley Stites Whatley, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1965 First Ave, Opelika, AL 36801 Phone: 334-705-0012 Fax: 334-705-0378 | |
William R Blythe, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1965 1st Ave, Opelika, AL 36801 Phone: 334-705-0012 Fax: 334-705-0378 |